These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37751826)

  • 1. Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments.
    Qu H; Li L; Chen H; Tang M; Cheng W; Lin TY; Li L; Li B; Xue X
    J Control Release; 2023 Nov; 363():361-375. PubMed ID: 37751826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded
    Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S
    Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
    Yasothamani V; Vivek R
    J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma.
    Chen Y; Wu B; Shang H; Sun Y; Tian H; Yang H; Wang C; Wang X; Cheng W
    Int J Nanomedicine; 2023; 18():6059-6073. PubMed ID: 37908671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
    Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
    ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-/immuno-therapy for cancer treatments.
    Chen H; Qu H; Pan Y; Cheng W; Xue X
    Biomaterials; 2025 Jan; 312():122745. PubMed ID: 39098306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
    Choi J; Shim MK; Yang S; Hwang HS; Cho H; Kim J; Yun WS; Moon Y; Kim J; Yoon HY; Kim K
    ACS Nano; 2021 Jul; 15(7):12086-12098. PubMed ID: 34165970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Microenvironment-Activatable Polymer Nano-Immunomodulator for Precision Cancer Photoimmunotherapy.
    Liu J; He S; Luo Y; Zhang Y; Du X; Xu C; Pu K; Wang J
    Adv Mater; 2022 Feb; 34(8):e2106654. PubMed ID: 34854147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast Activation Protein-α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy.
    Sun M; Yao S; Fan L; Fang Z; Miao W; Hu Z; Wang Z
    Small; 2022 Mar; 18(9):e2106296. PubMed ID: 34914185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers.
    Xue X; Qu H; Bo R; Zhang D; Zhu Z; Xiang B; Li L; Ricci M; Pan CX; Lin TY; Li Y
    Biomaterials; 2023 Aug; 299():122145. PubMed ID: 37172536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment.
    Sun K; Yu J; Hu J; Chen J; Song J; Chen Z; Cai Z; Lu Z; Zhang L; Wang Z
    Acta Biomater; 2022 Aug; 148():230-243. PubMed ID: 35724919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment-responsive macrophage-mediated immunotherapeutic drug delivery.
    Zhang X; Yue L; Cao L; Liu K; Yang S; Liang S; Liu L; Zhao C; Wu D; Wang Z; Tian R; Rao L
    Acta Biomater; 2024 Sep; 186():369-382. PubMed ID: 39097127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
    Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
    J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Acidic Microenvironment-Responsive Promodulator Iron Oxide Nanoparticles for Photothermal-Enhanced Chemodynamic Immunotherapy of Cancer.
    Chen S; Lv Y; Wang Y; Kong D; Xia J; Li J; Zhou Q
    ACS Biomater Sci Eng; 2023 Feb; 9(2):773-783. PubMed ID: 36598463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supramolecular prodrug-like nanotheranostics with dynamic and activatable nature for synergistic photothermal immunotherapy of metastatic cancer.
    Li Y; Mu X; Feng W; Gao M; Wang Z; Bai X; Ren X; Lu Y; Zhou X
    J Control Release; 2024 Mar; 367():354-365. PubMed ID: 38286337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.